Walgreens Scales Back Planned Store Closures Under New Ownership
Deerfield, Tuesday, 4 August 2026.
Walgreens will close under 100 U.S. stores in 2026—far fewer than the 700 originally projected—as new private equity owner Sycamore Partners optimizes operations across its 8,000 remaining locations.
Strategic Retrenchment Under New Ownership
Walgreens Boots Alliance is proceeding with plans to close fewer than 100 store locations across the United States in 2026, a significant reduction from previous projections [1][2]. This decision follows the company’s transition to private ownership under Sycamore Partners in August 2025, marking a strategic pivot aimed at optimizing the retail footprint rather than executing mass closures [2]. The move underscores a recalibration of the pharmacy giant’s operational strategy as it navigates compressed margins and shifting consumer behaviors [1].
Revision of Closure Targets
Initially, the company announced a three-year plan in June 2024 to close approximately 1,200 underperforming stores, with roughly 500 cuts planned for the preceding year [2]. However, the new ownership has scaled back the pace, with internal projections previously estimating around 700 closures for 2026 before settling on the current figure of fewer than 100 [2]. This adjustment reflects a focus on stabilizing the remaining network of approximately 8,000 stores, down from a peak of roughly 8,600 locations, representing a reduction of 600 stores from the previous count [3][4].
Immediate Impact on Local Communities
In New Jersey, two locations are scheduled for imminent closure, including the store at 33 River Road in Bogota, set to close by 6 August 2026 [3]. The second location, situated at 406 East Madison Avenue in Dumont, is planned to shut its doors by 3 September 2026 [4]. Prescriptions from these sites will be transferred to nearby branches in Teaneck and Bergenfield, with customers eligible for 90 days of free delivery following the closures [3][4].
Broader Sector Headwinds
The retail pharmacy sector continues to face structural challenges, with competitors like CVS Health closing over 1,100 locations since 2022 due to changing population patterns [1]. Additionally, Rite Aid completed a full shutdown of its remaining 89 stores after filing for bankruptcy twice between 2024 and 2026 [1]. These industry-wide contractions highlight the systemic pressures affecting brick-and-mortar pharmacy operations nationwide [1].
Future Outlook
Walgreens remains committed to improving the in-store experience and focusing on core pharmacy operations as part of its organizational contraction [1]. Company representatives have stated that team members are being supported through transitions, including opportunities for employment at other locations [3]. The streamlined approach aims to ensure uninterrupted service for patients while aligning the company’s footprint with long-term profitability goals [4].